These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34427102)

  • 1. Selecting Children with Vesicoureteral Reflux Who Are Most Likely to Benefit from Antibiotic Prophylaxis: Application of Machine Learning to RIVUR. Letter.
    Selvi I; Baydilli N
    J Urol; 2021 Nov; 206(5):1337-1338. PubMed ID: 34427102
    [No Abstract]   [Full Text] [Related]  

  • 2. Selecting Children with Vesicoureteral Reflux Who are Most Likely to Benefit from Antibiotic Prophylaxis: Application of Machine Learning to RIVUR.
    Bertsimas D; Li M; Estrada C; Nelson C; Scott Wang HH
    J Urol; 2021 Apr; 205(4):1170-1179. PubMed ID: 33289598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Reanalysis of the RIVUR Trial Using a Risk Classification System.
    Wang ZT; Wehbi E; Alam Y; Khoury A
    J Urol; 2018 Jun; 199(6):1608-1614. PubMed ID: 29198997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.
    Mathews R; Mattoo TK
    Adv Chronic Kidney Dis; 2015 Jul; 22(4):325-30. PubMed ID: 26088078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Workup after Initial Febrile Urinary Tract Infection: Using a Novel Machine Learning Model to Identify Children Most Likely to Benefit from Voiding Cystourethrogram.
    Advanced Analytics Group of Pediatric Urology and ORC Personalized Medicine Group
    J Urol; 2019 Jul; 202(1):144-152. PubMed ID: 30810465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicoureteral reflux: the RIVUR study and the way forward.
    Greenfield SP; Chesney RW; Carpenter M; Moxey-Mims M; Nyberg L; Hoberman A; Keren R; Matthews R; Mattoo T
    J Urol; 2008 Feb; 179(2):405-7. PubMed ID: 18076937
    [No Abstract]   [Full Text] [Related]  

  • 8. Vesicoureteral reflux and continuous prophylactic antibiotics.
    Lee T; Park JM
    Investig Clin Urol; 2017 Jun; 58(Suppl 1):S32-S37. PubMed ID: 28612058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux: a meta-analysis of randomized, controlled trials comparing dilated to nondilated vesicoureteral reflux.
    de Bessa J; de Carvalho Mrad FC; Mendes EF; Bessa MC; Paschoalin VP; Tiraboschi RB; Sammour ZM; Gomes CM; Braga LH; Bastos Netto JM
    J Urol; 2015 May; 193(5 Suppl):1772-7. PubMed ID: 25817142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observation of patients with vesicoureteral reflux off antibiotic prophylaxis: physician bias on patient selection and risk factors for recurrent febrile urinary tract infection.
    Drzewiecki BA; Thomas JC; Pope JC; Adams MC; Brock JW; Tanaka ST
    J Urol; 2012 Oct; 188(4 Suppl):1480-4. PubMed ID: 22906676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.
    Leslie B; Moore K; Salle JL; Khoury AE; Cook A; Braga LH; Bägli DJ; Lorenzo AJ
    J Urol; 2010 Sep; 184(3):1093-8. PubMed ID: 20650501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.
    Keren R; Carpenter MA; Hoberman A; Shaikh N; Matoo TK; Chesney RW; Matthews R; Gerson AC; Greenfield SP; Fivush B; McLurie GA; Rushton HG; Canning D; Nelson CP; Greenbaum L; Bukowski T; Primack W; Sutherland R; Hosking J; Stewart D; Elder J; Moxey-Mims M; Nyberg L
    Pediatrics; 2008 Dec; 122 Suppl 5(Suppl 5):S240-50. PubMed ID: 19018048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are prophylactic antibiotics indicated after a urinary tract infection?
    Mattoo TK
    Curr Opin Pediatr; 2009 Apr; 21(2):203-6. PubMed ID: 19663037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux?
    Hayashi Y; Kojima Y; Kamisawa H; Imura M; Mizuno K; Kohri K
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):51-8. PubMed ID: 20014901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Does Prevention of Recurrent Urinary Tract Infection not Result in Less Renal Scarring? A Deeper Dive into the RIVUR Trial.
    Wang HH; Kurtz M; Logvinenko T; Nelson C
    J Urol; 2019 Aug; 202(2):400-405. PubMed ID: 31026216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications for antibiotic prophylaxis in urinary tract infections].
    Pérez Méndez C; Ochoa Sangrador C;
    An Pediatr (Barc); 2007 Nov; 67(5):478-84. PubMed ID: 17991368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on childhood urinary tract infection and vesicoureteral reflux.
    Bell LE; Mattoo TK
    Semin Nephrol; 2009 Jul; 29(4):349-59. PubMed ID: 19615556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can cranberry juice be a substitute for cefaclor prophylaxis in children with vesicoureteral reflux?
    Nishizaki N; Someya T; Hirano D; Fujinaga S; Ohtomo Y; Shimizu T; Kaneko K
    Pediatr Int; 2009 Jun; 51(3):433-4. PubMed ID: 19438835
    [No Abstract]   [Full Text] [Related]  

  • 19. Vesicoureteral reflux: the role of antibiotic prophylaxis.
    Wald ER
    Pediatrics; 2006 Mar; 117(3):919-22. PubMed ID: 16510674
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary tract infections in children: a review.
    Buonsenso D; Cataldi L
    Minerva Pediatr; 2012 Apr; 64(2):145-57. PubMed ID: 22495189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.